Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors
- 5 February 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (6), 882-887
- https://doi.org/10.1016/j.vaccine.2008.11.077
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsVaccine, 2007
- A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine IntroductionMayo Clinic Proceedings, 2007
- Cost-Effectiveness of a Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsClinical Infectious Diseases, 2007
- Cost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsAnnals of Internal Medicine, 2006
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of LifeClinical Infectious Diseases, 2004
- Risk factors for postherpetic neuralgia in patients with herpes zosterNeurology, 2004
- Herpes ZosterNew England Journal of Medicine, 2002
- The lifetime occurrence of Herpes zoster and prevalence of post‐herpetic neuralgia: A retrospective survey in an elderly populationEuropean journal of pain, 1999
- Immunization to reduce the frequency and severity of herpes zoster and its complicationsNeurology, 1995